Skip to main content
OpenTrials

Clinical trial condition

Gastric Neoplasms

Explore clinical trials studying Gastric Neoplasms. Study availability and eligibility vary by location and protocol.

14 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Gastric Neoplasms trial results

Recruiting

Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios

NCT06848400

Conditions
Digestive System Diseases, Digestive System Neoplasms, Duodenal Diseases, +20 more
Locations
  • Guangdong Provincial Hospital of Traditional Chinese Medicine Guangzhou, Guangdong, China
  • Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Renhua People's Hospital Shaoguan, Guangdong, China
View Trial Details
Recruiting

The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer

NCT05551416

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +8 more
Locations
  • Hospital Comarcal de Inca Palma de Mallorca, Balearic Islands, Spain
  • Hospital de Llevant Porto Cristo, Balearic Islands, Spain
  • Hospital General de Granollers Granollers, Barcelona, Spain
  • Consorci Sanitari de Terrassa Terrassa, Barcelona, Spain
View all 15 locations
View Trial Details
Completed

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

NCT03615326

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Neoplasms, +8 more
Locations
  • UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) ( Site 0045) Los Angeles, California, United States
  • Pacific Cancer Care ( Site 0063) Monterey, California, United States
  • UC Irvine Medical Center/Chao Family Comprehensive Cancer Center ( Site 0050) Orange, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center - Plantation ( Site 0026) Miami, Florida, United States
View all 192 locations
View Trial Details
Completed

Chromogranin A as Blood Marker in Cancer Patients

NCT03817866

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +25 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Charité - Universitätsmedizin Berlin Berlin, Germany
View Trial Details

Related conditions